BridgeMD
Tests treatment safety and results for Locally Advanced Rectal Carcinoma
Official title Exercise for Improving Long-course Chemoradiotherapy Efficacy in People With Locally Advanced Rectal Cancer
ClinicalTrials.gov ID: NCT06276686
What this study is testing
- What it's testing
- This is a single arm feasibility study of exercise for improving long- course neoadjuvant chemoradiotherapy (NACRT) efficacy in people diagnosed with locally advanced rectal cancer. The study aims to recruit up to 30 patients from the Queen's Centre for Oncology and Haematology of Castle Hill Hospital, Cottingham, diagnosed with locally advanced rectal cancer.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years or older
- Have been diagnosed with locally advanced rectal cancer using MRI (Magnetic Resonance Imaging) and histological finding
- Have been offered long-course neoadjuvant chemoradiotherapy in the Queens Centre, Castle Hill Hospital
- Willing and able to comply with all study requirements
- Able and willing to voluntarily give informed consent to take part.
You likely can't join if
- Inability to understand basic written and spoken English, as research materials will all be written in English.
- Any movement deficiencies limiting ability to engage in exercise.
- Impaired cognition and/or capacity limiting ability to provide informed consent.
- Cardiovascular and/or cardiopulmonary conditions that will impede ability to safely perform exercise.
- Severe psychiatric disorders.
- With any other health condition which oncologists and research team agrees will impede ability to safely perform exercises.
See the full eligibility criteria
- 18 years or older
- Have been diagnosed with locally advanced rectal cancer using MRI (Magnetic Resonance Imaging) and histological finding
- Have been offered long-course neoadjuvant chemoradiotherapy in the Queens Centre, Castle Hill Hospital
- Willing and able to comply with all study requirements
- Able and willing to voluntarily give informed consent to take part.
- Inability to understand basic written and spoken English, as research materials will all be written in English.
- Any movement deficiencies limiting ability to engage in exercise.
- Impaired cognition and/or capacity limiting ability to provide informed consent.
- Cardiovascular and/or cardiopulmonary conditions that will impede ability to safely perform exercise.
- Severe psychiatric disorders.
- With any other health condition which oncologists and research team agrees will impede ability to safely perform exercises.
- Presence of metastatic cancer.
The study team makes the final eligibility decision.
Where it's taking place
- Cottingham, East Yorkshire, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cottingham, East Yorkshire, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.